❯ Rightway raises $155 million to expand pharmacy benefits and AI

The customer problemRightway serves employers by combining pharmacist guidance, drug selection and pricing management to help workers obtain appropriate medications while controlling company spending. It says 45 Fortune 500 companies are customers. Its contracts emphasize a cap on total pharmacy spend, net-cost pricing for certain expensive drugs and full rebate pass-through, positioning it differently from intermediaries that can benefit when drug prices rise.

Business historyRightway built its business by combining pharmacy-benefit management with pharmacist-led navigation. Employers pay to manage benefits, while employees get help choosing appropriate medication and understanding costs. The company says 45 Fortune 500 firms are clients and highlights total-spend guarantees, net-cost pricing for some expensive drugs and full rebate pass-through. It established employer and member relationships before adding AI to back-end workflows.

The financingRightway announced a $155 million Series E led by Francisco Partners, with existing investors Thrive Capital and Khosla Ventures participating. The pharmacy-benefit and care-navigation company will invest in growth, back-end AI and its pharmacy technology.

Industry impactRightway will expand pharmacy technology and AI capabilities. Traditional pharmacy supply-chain fees and rebates can obscure an employer’s true cost; a model that lowers total spending while preserving clinical support could pressure incumbents. The test is actual drug spending, members’ treatment outcomes and service experience, not the number of AI features launched.

▪ SIGNALAI in pharmacy benefits has to show up in measurable drug spending and accessible professional care.